SOST and obesity due to melanocortin 4 receptor deficiency: In addition to decreased fat mass, Kim et al. showed that global ablation or pharmacologic inhibition of sclerostin led to improved insulin sensitivity and protection from diet-induced obesity that was associated with the “beiging” of peripheral WAT [13].